GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (STU:82P) » Definitions » E10

Pacira BioSciences (STU:82P) E10 : €0.30 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacira BioSciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pacira BioSciences's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.175. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.30 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pacira BioSciences was 75.30% per year. The lowest was 74.10% per year. And the median was 74.70% per year.

As of today (2024-06-09), Pacira BioSciences's current stock price is €26.20. Pacira BioSciences's E10 for the quarter that ended in Mar. 2024 was €0.30. Pacira BioSciences's Shiller PE Ratio of today is 87.33.

During the past 13 years, the highest Shiller PE Ratio of Pacira BioSciences was 500.88. The lowest was 79.55. And the median was 173.06.


Pacira BioSciences E10 Historical Data

The historical data trend for Pacira BioSciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences E10 Chart

Pacira BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.59 -0.57 -0.28 -0.07 0.23

Pacira BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 0.07 0.15 0.23 0.30

Competitive Comparison of Pacira BioSciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's Shiller PE Ratio falls into.



Pacira BioSciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacira BioSciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.175/131.7762*131.7762
=0.175

Current CPI (Mar. 2024) = 131.7762.

Pacira BioSciences Quarterly Data

per share eps CPI Adj_EPS
201406 -0.103 100.560 -0.135
201409 -0.062 100.428 -0.081
201412 0.114 99.070 0.152
201503 0.028 99.621 0.037
201506 0.000 100.684 0.000
201509 0.071 100.392 0.093
201512 -0.064 99.792 -0.085
201603 -0.090 100.470 -0.118
201606 -0.187 101.688 -0.242
201609 -0.526 101.861 -0.680
201612 -0.104 101.863 -0.135
201703 -0.486 102.862 -0.623
201706 -0.436 103.349 -0.556
201709 -0.159 104.136 -0.201
201712 0.093 104.011 0.118
201803 -0.211 105.290 -0.264
201806 0.051 106.317 0.063
201809 -0.017 106.507 -0.021
201812 0.176 105.998 0.219
201903 -0.062 107.251 -0.076
201906 0.053 108.070 0.065
201909 -0.136 108.329 -0.165
201912 -0.108 108.420 -0.131
202003 0.172 108.902 0.208
202006 -0.151 108.767 -0.183
202009 2.496 109.815 2.995
202012 0.263 109.897 0.315
202103 0.193 111.754 0.228
202106 0.349 114.631 0.401
202109 0.332 115.734 0.378
202112 -0.106 117.630 -0.119
202203 0.136 121.301 0.148
202206 0.378 125.017 0.398
202209 -0.020 125.227 -0.021
202212 -0.208 125.222 -0.219
202303 -0.402 127.348 -0.416
202306 0.471 128.729 0.482
202309 0.216 129.860 0.219
202312 0.477 129.419 0.486
202403 0.175 131.776 0.175

Add all the adjusted EPS together and divide 10 will get our e10.


Pacira BioSciences  (STU:82P) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pacira BioSciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26.20/0.3
=87.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pacira BioSciences was 500.88. The lowest was 79.55. And the median was 173.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pacira BioSciences E10 Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (STU:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (STU:82P) Headlines

No Headlines